Santhera Pharmaceuticals Holding competitorsClear all

Santhera Pharmaceuticals Holding's top competitors include Cyclacel Pharmaceuticals, Roche, Rigel Pharmaceuticals and Novartis.
Santhera Pharmaceuticals Holding
Santhera Pharmaceuticals Holding
Santhera Pharmaceuticals Holding is a drug discovery and development company.
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals develops oral therapies to treat cancers and other serious diseases.
Roche
Roche
Roche Holding is a diagnostics and pharmaceutical company.
Rigel Pharmaceuticals
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Novartis
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
Founding Date
Founding Date
2004
Founding Date
1992
Founding Date
1896
Founding Date
1996
Founding Date
1996
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Pratteln, CH HQ
Locations
Berkeley Heights, US HQ
Dundee City, GB
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
Bella Vista, AU
North Ryde, AU
Sydney, AU
Wien, AT
see more
Locations
South San Francisco, US HQ
Locations
Basel, CH HQ
Núñez, AR
Wien, AT
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
see more
Employees
Employees
11240% increase
Employees
1417% increase
Employees
94,4421% increase
Employees
15853% increase
Employees
125,1613% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
9.5 m
Valuation ($)
N/A
Valuation ($)
346.1 m
Valuation ($)
175.5 b
Twitter followers
Twitter followers
406
Twitter followers
N/A
Twitter followers
197 k
Twitter followers
1.5 k
Twitter followers
254.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
138
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
23
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
9.7
Average likes per tweet (last 30 days)
0.4
Average likes per tweet (last 30 days)
20.2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
81.88%
Percentage of tweets with engagement (last 30 days)
21.43%
Percentage of tweets with engagement (last 30 days)
34.78%
Alexa Website Rank
Alexa Website Rank
871008
Alexa Website Rank
898702
Alexa Website Rank
74758
Alexa Website Rank
332872
Alexa Website Rank
93405

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
CHF48.1b (FY, 2015)
Revenue (est.)
$44.5m (FY, 2018)
Revenue (est.)
$49.1b (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
CHF15.5b (FY, 2015)
Cost of goods
$287k (FY, 2018)
Cost of goods
$17.2b (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
CHF32.7b (FY, 2015)
Gross profit
$44.2m (FY, 2018)
Gross profit
$31.9b (FY, 2017)
Net income
Net income
N/A
Net income
($7.3m) (FY, 2018)
Net income
CHF9.1b (FY, 2015)
Net income
($70.5m) (FY, 2018)
Net income
$7.7b (FY, 2017)

Operating

Major Approvals (US, EU, JP)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
12 (Y, 2016)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
16 (FY, 2017)
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
6 (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 25.9m
Total funding raised
$ 152.2m
Total funding raised
$ 2.8b
Total funding raised
$ 130m
Total funding raised
$ 6.5m
For sources of this data, please see the company profile

View company profiles

Cyclacel Pharmaceuticals
HQ
Berkeley Heights, US
Employees
14↑ 17% increase

Cyclacel Pharmaceuticals develops oral therapies to treat cancers and other serious diseases.

View company
Roche
HQ
Basel, CH
Employees
94,442↑ 1% increase

Roche Holding is a diagnostics and pharmaceutical company.

View company
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
158

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

View company
Novartis
HQ
Basel, CH
Employees
125,161↑ 3% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company